about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tr...
Read More
1.66
-0.02
(-1.19%)
490.6K
XNAS Volume
XNAS 25 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..